Back to Journals » Cancer Management and Research » Volume 11

Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models

Authors Chen D, Lin X, Zhang C, An G, Li Z, Dong B, Shen L, Gao J, Zhang X

Received 11 September 2018

Accepted for publication 27 December 2018

Published 11 February 2019 Volume 2019:11 Pages 1349—1362

DOI https://doi.org/10.2147/CMAR.S187219

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 3

Editor who approved publication: Dr Beicheng Sun


Dongshao Chen,1,* Xiaoting Lin,1,* Cheng Zhang,1 Guo An,2 Zhongwu Li,3 Bin Dong,3 Lin Shen,1 Jing Gao,1 Xiaotian Zhang1

1Department of Gastrointestinal Oncology; 2Department of Laboratory Animal; 3Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China

*These authors contributed equally to this work

Background: Characterized by elevated AFP levels in serum, AFP-producing gastric cancer (APGC) is a very special type of gastric cancer (GC) that is difficult to treat and has poor prognosis. However, little is known about the role of AFP in GC, which was investigated in this study with in vitro and in vivo experiments.
Methods: APGC cells were established with lentivirus infection and validated by PCR assay and ELISA in HCG27 and AGS cells. Cell growth, migration, and invasion were determined by CCK8, transwell assays, and animal experiments. RNA sequencing, Western blot, dual-luciferase-reporter assays, and RNA interference were employed to understand mechanisms underlying AFP activity, followed by therapeutic investigations for APGC.
Results: APGC cells featured significantly increased AFP levels in cellular supernatants. AFP potentiated growth and aggression in GC cell lines and their derived xenografts. Wnt-signaling activation was responsible for AFP function, indicated by decreased Axin 1 and pGSK3β, followed by cascade activation of β-catenin, downstream transcription factors TCF1/TCF7, and the target gene – c-Myc. Wnt-signaling blockade by Axin 1 rescue or pathway inhibitor XAV939 reversed AFP function, suggesting the potential therapeutic value of APGC.
Conclusion: AFP played a critical role in APGC through activating Wnt signaling, and targeting Wnt pathways might be a promising strategy against APGC.

Keywords: alpha-fetoprotein, AFP, AFP-producing gastric cancer, APGC, Axin 1, Wnt signaling, Wnt-signaling inhibitor

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]